Logo image of JNVR

JANOVER INC (JNVR) Stock Fundamental Analysis

NASDAQ:JNVR - Nasdaq - US47100L3015 - Common Stock - Currency: USD

52.875  -19.2 (-26.64%)

After market: 52.48 -0.4 (-0.75%)

Fundamental Rating

3

Overall JNVR gets a fundamental rating of 3 out of 10. We evaluated JNVR against 53 industry peers in the Consumer Finance industry. While JNVR has a great health rating, there are worries on its profitability. JNVR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year JNVR has reported negative net income.
In the past year JNVR has reported a negative cash flow from operations.
JNVR Yearly Net Income VS EBIT VS OCF VS FCFJNVR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -1M -2M -3M

1.2 Ratios

The Return On Assets of JNVR (-76.21%) is worse than 96.23% of its industry peers.
With a Return On Equity value of -86.40%, JNVR is not doing good in the industry: 92.45% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -76.21%
ROE -86.4%
ROIC N/A
ROA(3y)-77.2%
ROA(5y)N/A
ROE(3y)-227.15%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JNVR Yearly ROA, ROE, ROICJNVR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for JNVR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JNVR Yearly Profit, Operating, Gross MarginsJNVR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -50 -100 -150

More info and screens

9

2. Health

2.1 Basic Checks

JNVR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, JNVR has less shares outstanding
JNVR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
JNVR Yearly Shares OutstandingJNVR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M
JNVR Yearly Total Debt VS Total AssetsJNVR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2M 4M 6M

2.2 Solvency

An Altman-Z score of 83.90 indicates that JNVR is not in any danger for bankruptcy at the moment.
JNVR has a better Altman-Z score (83.90) than 100.00% of its industry peers.
There is no outstanding debt for JNVR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 83.9
ROIC/WACCN/A
WACC8.98%
JNVR Yearly LT Debt VS Equity VS FCFJNVR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M 4M

2.3 Liquidity

JNVR has a Current Ratio of 8.89. This indicates that JNVR is financially healthy and has no problem in meeting its short term obligations.
JNVR has a better Current ratio (8.89) than 92.45% of its industry peers.
A Quick Ratio of 8.89 indicates that JNVR has no problem at all paying its short term obligations.
JNVR has a better Quick ratio (8.89) than 92.45% of its industry peers.
Industry RankSector Rank
Current Ratio 8.89
Quick Ratio 8.89
JNVR Yearly Current Assets VS Current LiabilitesJNVR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for JNVR have decreased strongly by -685.50% in the last year.
JNVR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.70%.
The Revenue has been growing by 8.69% on average over the past years. This is quite good.
EPS 1Y (TTM)-685.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-97.94%
Revenue 1Y (TTM)-13.7%
Revenue growth 3Y8.69%
Revenue growth 5YN/A
Sales Q2Q%6.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JNVR Yearly Revenue VS EstimatesJNVR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 500K 1M 1.5M 2M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JNVR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JNVR Price Earnings VS Forward Price EarningsJNVR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JNVR Per share dataJNVR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

JNVR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JANOVER INC

NASDAQ:JNVR (4/17/2025, 8:00:02 PM)

After market: 52.48 -0.4 (-0.75%)

52.875

-19.2 (-26.64%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.44%
Inst Owner Change0%
Ins Owners52.89%
Ins Owner Change-862.79%
Market Cap77.73M
AnalystsN/A
Price TargetN/A
Short Float %1.87%
Short Ratio0.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 42.68
P/FCF N/A
P/OCF N/A
P/B 19.65
P/tB 27.38
EV/EBITDA N/A
EPS(TTM)-1.73
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.99
FCFYN/A
OCF(TTM)-1.97
OCFYN/A
SpS1.24
BVpS2.69
TBVpS1.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -76.21%
ROE -86.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-77.2%
ROA(5y)N/A
ROE(3y)-227.15%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.98%
Cap/Sales 1.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.89
Quick Ratio 8.89
Altman-Z 83.9
F-Score4
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-685.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-97.94%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.7%
Revenue growth 3Y8.69%
Revenue growth 5YN/A
Sales Q2Q%6.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-463.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-457.04%
OCF growth 3YN/A
OCF growth 5YN/A